Scientists at the Buck Institute and UC San Francisco discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deterioration in women, revealing an unexpected connection between neurological and skeletal health.
New research reveals that approximately 10% of people carry specific genetic variants that make popular diabetes and weight-loss drugs like Ozempic and Wegovy significantly less effective, providing the first genetic explanation for variable drug response.
Researchers at the University of Tartu Faculty of Medicine have identified a rare variant in the MGRN1 gene that may cause congenital heart malformations in fetuses, a gene not previously associated with cardiac defects.
